Skip to main content

Dacarbazine Injection

Last Updated: February 6, 2023
Status: Current

Products Affected - Description
    • Dacarbazine lyophilized powder for injection, Fresenius Kabi, 200 mg, vial, 1 count, NDC 63323-0128-20
    • Dacarbazine lyophilized powder for injection, Teva, 200 mg, vial, 1 count, NDC 00703-5075-01
    • Dacarbazine lyophilized powder for injection, Teva, 200 mg, vial, 10 count, NDC 00703-5075-03
Reason for the Shortage
    • Fresenius Kabi did not provide a reason for the shortage.
    • Hikma has dacarbazine injection available.
    • Teva has dacarbazine injection on shortage due to manufacturing delays.
Available Products
    • Dacarbazine lyophilized powder for injection, Fresenius Kabi, 100 mg, vial, 1 count, NDC 63323-0127-10
    • Dacarbazine lyophilized powder for injection, Hikma, 200 mg, vial, 1 count, NDC 55390-0090-10

Estimated Resupply Dates

    • Fresenius Kabi has dacarbazine 200 mg vials on back order and the company estimates a release date of early-February 2023.
    • Teva has dacarbazine 200 mg vials in 1 count and 10 count temporarily unavailable and the company cannot estimate a release date.

Updated

Updated February 6, 2023 by Michelle Wheeler, PharmD, Drug Information Specialist. Created July 23, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2023, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.